These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 16318861)
21. Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons. Alvira D; Tajes M; Verdaguer E; de Arriba SG; Allgaier C; Matute C; Trullas R; Jiménez A; Pallàs M; Camins A Neuroscience; 2007 Apr; 146(1):350-65. PubMed ID: 17343987 [TBL] [Abstract][Full Text] [Related]
22. Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Jung TW; Lee JY; Shim WS; Kang ES; Kim JS; Ahn CW; Lee HC; Cha BS Biochem Biophys Res Commun; 2006 May; 343(2):564-70. PubMed ID: 16554029 [TBL] [Abstract][Full Text] [Related]
23. Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine. Virmani A; Gaetani F; Binienda Z; Xu A; Duhart H; Ali SF Ann N Y Acad Sci; 2004 Oct; 1025():267-73. PubMed ID: 15542726 [TBL] [Abstract][Full Text] [Related]
24. Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices. Maruoka N; Murata T; Omata N; Takashima Y; Fujibayashi Y; Wada Y Neurotoxicology; 2007 May; 28(3):672-8. PubMed ID: 17391768 [TBL] [Abstract][Full Text] [Related]
25. High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease. Jia H; Li X; Gao H; Feng Z; Li X; Zhao L; Jia X; Zhang H; Liu J J Neurosci Res; 2008 Jul; 86(9):2083-90. PubMed ID: 18381761 [TBL] [Abstract][Full Text] [Related]
27. Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells. Han YS; Lee CS Eur J Pharmacol; 2009 Feb; 604(1-3):36-44. PubMed ID: 19135049 [TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of catalpol against MPP(+)-induced oxidative stress in mesencephalic neurons. Tian YY; Jiang B; An LJ; Bao YM Eur J Pharmacol; 2007 Jul; 568(1-3):142-8. PubMed ID: 17512520 [TBL] [Abstract][Full Text] [Related]
29. Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis. Cheng YF; Zhu GQ; Wang M; Cheng H; Zhou A; Wang N; Fang N; Wang XC; Xiao XQ; Chen ZW; Li QL Neurosci Res; 2009 Jan; 63(1):52-8. PubMed ID: 19022306 [TBL] [Abstract][Full Text] [Related]
30. Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis. Ahn KH; Kim YS; Kim SY; Huh Y; Park C; Jeong JW Neurosci Lett; 2009 Jan; 449(2):93-7. PubMed ID: 19000740 [TBL] [Abstract][Full Text] [Related]
31. Oral administration of coenzyme Q(10) prevents cytochrome c release from mitochondria induced by 1-methyl-4-phenylpyridinium ion in mouse brain synaptosomes. Mitsumoto Y; Kobayashi S; Matsushima H; Muroyama A; Yoshimura I Neurosci Lett; 2009 Sep; 463(1):22-5. PubMed ID: 19638300 [TBL] [Abstract][Full Text] [Related]
32. MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine. Boada J; Cutillas B; Roig T; Bermúdez J; Ambrosio S Biochem Biophys Res Commun; 2000 Feb; 268(3):916-20. PubMed ID: 10679305 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells. Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091 [TBL] [Abstract][Full Text] [Related]
34. Copper sulfate pretreatment prevents mitochondrial electron transport chain damage and apoptosis against MPP Rubio-Osornio M; Orozco-Ibarra M; Díaz-Ruiz A; Brambila E; Boll MC; Monroy-Noyola A; Guevara J; Montes S; Ríos C Chem Biol Interact; 2017 Jun; 271():1-8. PubMed ID: 28442376 [TBL] [Abstract][Full Text] [Related]
35. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221 [TBL] [Abstract][Full Text] [Related]
36. dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease. Huang JZ; Chen YZ; Su M; Zheng HF; Yang YP; Chen J; Liu CF Neurosci Lett; 2010 May; 475(2):89-94. PubMed ID: 20347933 [TBL] [Abstract][Full Text] [Related]
37. Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum. Obata T Toxicology; 2006 May; 222(1-2):46-52. PubMed ID: 16500014 [TBL] [Abstract][Full Text] [Related]
38. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563 [TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336 [TBL] [Abstract][Full Text] [Related]